{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:35Z","timestamp":1790007275380,"version":"4.0.1"},"reference-count":249,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13760-022-02137-2","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T19:02:36Z","timestamp":1668625356000},"page":"9-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A review of the potential neurological adverse events of COVID-19 vaccines"],"prefix":"10.1007","volume":"123","author":[{"given":"Zeinab","family":"Mohseni Afshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Babazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alizadeh-Khatir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ali","family":"Taghizadeh Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tavakolli Pirzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Mojadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-9370","authenticated-orcid":false,"given":"Mohammad","family":"Barary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"5","key":"2137_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26065","volume":"89","author":"AL Goss","year":"2021","unstructured":"Goss AL, Samudralwar RD, Das RR, Nath A (2021) ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol 89(5):856\u2013857","journal-title":"Ann Neurol"},{"key":"2137_CR2","doi-asserted-by":"crossref","unstructured":"Malhotra HS, Gupta P, Prabhu V, Kumar Garg R, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. QJM: An International Journal of Medicine. 2021 Aug;114(8):591-3.","DOI":"10.1093\/qjmed\/hcab069"},{"key":"2137_CR3","doi-asserted-by":"crossref","unstructured":"von Csefalvay C. A case-control study of autoimmune AEFIs following COVID-19 vaccination reported to VAERS. medRxiv. 2021 Jan 1.","DOI":"10.1101\/2021.07.06.21260074"},{"key":"2137_CR4","unstructured":"Al Battah A, Hammamy R. Multiple sclerosis flare secondary to COVID-19 vaccine, a case report. Authorea Preprints. 2021 Jul 25."},{"issue":"6","key":"2137_CR5","first-page":"1302","volume":"4","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA, Fiorini AC (2021) SARS-CoV-2 infection\/vaccination associated new or exacerbating immune-mediated disease. J Med Res Health Sci 4(6):1302\u20131304","journal-title":"J Med Res Health Sci"},{"issue":"5","key":"2137_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N et al (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mrna\/dna sars-cov-2 vaccination. Vaccines (Basel) 9(5):435","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"2137_CR7","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","volume":"106","author":"K Althaus","year":"2021","unstructured":"Althaus K, Moller P, Uzun G, Singh A, Beck A, Bettag M et al (2021) Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 106(8):2170\u20132179","journal-title":"Haematologica"},{"issue":"31","key":"2137_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","volume":"70","author":"AM Hause","year":"2021","unstructured":"Hause AM, Gee J, Baggs J, Abara WE, Marquez P, Thompson D et al (2021) COVID-19 vaccine safety in adolescents aged 12\u201317 years-United States, december 14, 2020-july 16, 2021. MMWR Morb Mortal Wkly Rep 70(31):1053\u20131058","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2137_CR9","doi-asserted-by":"publisher","first-page":"015","DOI":"10.30574\/wjbphs.2021.7.1.0072","volume":"7","author":"OI Ogidi","year":"2021","unstructured":"Ogidi OI, Berefagha WL, Okara E (2021) Covid-19 vaccination: the pros and cons. World J Biol Pharm Health Sci 7(1):015\u2013022","journal-title":"World J Biol Pharm Health Sci"},{"key":"2137_CR10","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Grimshaw M, Hern\u00e1ndez-Vanegas LE, N\u00fa\u00f1ez I, Hern\u00e1ndez-Valdivia N, Carrillo-Garc\u00eda DA, Michel-Ch\u00e1vez A, Galnares-Olalde JA, Carbajal-Sandoval G, del Mar Saniger-Alba M, Carrillo-Mezo RA, Fragoso-Saavedra S. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clinical Immunology. 2021 Aug 1;229:108786.","DOI":"10.1016\/j.clim.2021.108786"},{"issue":"6","key":"2137_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/ggi.14163","volume":"21","author":"LF Zavala-Jonguitud","year":"2021","unstructured":"Zavala-Jonguitud LF, Perez-Garcia CC (2021) Delirium triggered by COVID-19 vaccine in an elderly patient. Geriatr Gerontol Int 21(6):540","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"2137_CR12","volume":"13","author":"H Iftikhar","year":"2021","unstructured":"Iftikhar H, Noor SMU, Masood M, Bashir K (2021) Bell\u2019s Palsy after 24 hours of mrna-1273 sars-cov-2 vaccine. Cureus 13(6):e15935","journal-title":"Cureus"},{"issue":"5","key":"2137_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/1099-1654(200009\/10)10:5<285::AID-RMV269>3.0.CO;2-H","volume":"10","author":"DP McCormick","year":"2000","unstructured":"McCormick DP, Spruance SL (2000) Herpes simplex virus as a cause of Bell\u2019s palsy. Rev Med Virol 10(5):285","journal-title":"Rev Med Virol"},{"issue":"8","key":"2137_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamaoto.2021.1266","volume":"147","author":"A Tamaki","year":"2021","unstructured":"Tamaki A, Cabrera CI, Li S, Rabbani C, Thuener JE, Rezaee RP et al (2021) Incidence of Bell Palsy in patients with covid-19. JAMA Otolaryngol Head Neck Surg 147(8):767\u2013768","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2137_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13881","author":"IO Oke","year":"2021","unstructured":"Oke IO, Oladunjoye OO, Oladunjoye AO, Paudel A, Zimmerman R (2021) Bell\u2019s Palsy as a late neurologic manifestation of covid-19 infection. Cureus. https:\/\/doi.org\/10.7759\/cureus.13881","journal-title":"Cureus"},{"issue":"2","key":"2137_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ccr3.3631","volume":"9","author":"A Bastola","year":"2021","unstructured":"Bastola A, Sah R, Nepal G, Gajurel BP, Rajbhandari SK, Chalise BS et al (2021) Bell\u2019s palsy as a possible neurological complication of COVID-19: a case report. Clinical Case Reports 9(2):747\u2013750","journal-title":"Clinical Case Reports"},{"issue":"5","key":"2137_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3329\/jhpn.v27i5.3783","volume":"27","author":"H Alp","year":"2009","unstructured":"Alp H, Tan H, Orbak Z (2009) Bell\u2019s palsy as a possible complication of hepatitis B vaccination in a child. J Health Popul Nutr 27(5):707","journal-title":"J Health Popul Nutr"},{"issue":"15","key":"2137_CR18","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.vaccine.2006.10.006","volume":"25","author":"CH Chou","year":"2007","unstructured":"Chou CH, Liou WP, Hu KI, Loh CH, Chou CC, Chen YH (2007) Bell\u2019s palsy associated with influenza vaccination: two case reports. Vaccine 25(15):2839\u20132841","journal-title":"Vaccine"},{"key":"2137_CR19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2084","author":"HF Tseng","year":"2017","unstructured":"Tseng HF, Sy LS, Ackerson BK, Hechter RC, Tartof SY, Haag M et al (2017) Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2016-2084","journal-title":"Pediatrics"},{"issue":"10","key":"2137_CR20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1007\/s00415-021-10462-4","volume":"268","author":"G Colella","year":"2021","unstructured":"Colella G, Orlandi M, Cirillo N (2021) Bell\u2019s palsy following COVID-19 vaccination. J Neurol 268(10):3589\u20133591","journal-title":"J Neurol"},{"key":"2137_CR21","doi-asserted-by":"crossref","unstructured":"Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno MJ, de la Nogal-Fernandez B. Bell\u2019s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology. 2022 Jan;269(1):47-8.","DOI":"10.1007\/s00415-021-10617-3"},{"issue":"7838","key":"2137_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/d41586-020-03542-4","volume":"588","author":"H Ledford","year":"2020","unstructured":"Ledford H (2020) US authorization of first COVID vaccine marks new phase in safety monitoring. Nature 588(7838):377\u2013378","journal-title":"Nature"},{"issue":"2","key":"2137_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15388\/Amed.2021.28.2.7","volume":"28","author":"S Pothiawala","year":"2021","unstructured":"Pothiawala S (2021) Bell\u2019s Palsy after second dose of moderna COVID-19 Vaccine: coincidence or causation? Acta medica Lituanica. 28(2):7","journal-title":"Acta medica Lituanica."},{"issue":"9","key":"2137_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40261-020-00952-0","volume":"40","author":"A Kamath","year":"2020","unstructured":"Kamath A, Maity N, Nayak MA (2020) Facial paralysis following influenza vaccination: a disproportionality analysis using the vaccine adverse event reporting system database. Clin Drug Investig 40(9):883\u2013889","journal-title":"Clin Drug Investig"},{"key":"2137_CR25","doi-asserted-by":"crossref","unstructured":"Principi N, Esposito S. Do vaccines have a role as a cause of autoimmune neurological syndromes?. Frontiers in Public Health. 2020 Jul 28;8:361.","DOI":"10.3389\/fpubh.2020.00361"},{"key":"2137_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2021.03.005","author":"T Soeiro","year":"2021","unstructured":"Soeiro T, Salvo F, Pariente A, Grandvuillemin A, Jonville-B\u00e9ra A-P, Micallef J (2021) Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell\u2019s palsy. Therapie. https:\/\/doi.org\/10.1016\/j.therap.2021.03.005","journal-title":"Therapie"},{"issue":"7","key":"2137_CR27","doi-asserted-by":"publisher","first-page":"e243829","DOI":"10.1136\/bcr-2021-243829","volume":"14","author":"A Burrows","year":"2021","unstructured":"Burrows A, Bartholomew T, Rudd J, Walker D (2021) Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP 14(7):e243829","journal-title":"BMJ Case Reports CP"},{"key":"2137_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100217","volume":"13","author":"M Repajic","year":"2021","unstructured":"Repajic M, Lai XL, Xu P, Liu A (2021) Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy. Brain Behav Immun Health 13:100217","journal-title":"Brain Behav Immun Health"},{"key":"2137_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00451-5","author":"EYF Wan","year":"2021","unstructured":"Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC et al (2021) Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(21)00451-5","journal-title":"Lancet Infect Dis"},{"key":"2137_CR30","doi-asserted-by":"crossref","unstructured":"Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. bmj. 2021 Jun 14;373.","DOI":"10.1101\/2021.03.25.21254315"},{"issue":"9","key":"2137_CR31","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S1473-3099(21)00273-5","volume":"21","author":"N Cirillo","year":"2021","unstructured":"Cirillo N, Doan R (2021) Bell\u2019s palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet Infect Dis 21(9):1210\u20131211","journal-title":"Lancet Infect Dis"},{"key":"2137_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/0194599813505967","author":"RF Baugh","year":"2013","unstructured":"Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R et al (2013) Clinical practice guideline: Bell\u2019s palsy. Otolaryngology-Head Neck Surg. https:\/\/doi.org\/10.1177\/0194599813505967","journal-title":"Otolaryngology-Head Neck Surg"},{"issue":"4","key":"2137_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","volume":"32","author":"P Haber","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F (2009) Vaccines and Guillain-Barre syndrome. Drug Saf 32(4):309\u2013323","journal-title":"Drug Saf"},{"issue":"22","key":"2137_CR34","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1212\/WNL.0000000000011881","volume":"96","author":"AMM Loza","year":"2021","unstructured":"Loza AMM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA (2021) Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology 96(22):1052\u20131054","journal-title":"Neurology"},{"issue":"4","key":"2137_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2478\/jtim-2019-0028","volume":"7","author":"A Babazadeh","year":"2019","unstructured":"Babazadeh A, Mohseni Afshar Z, Javanian M, Mohammadnia-Afrouzi M, Karkhah A, Masrour-Roudsari J et al (2019) Influenza vaccination and guillain-barre syndrome: reality or fear. J Transl Int Med 7(4):137\u2013142","journal-title":"J Transl Int Med"},{"issue":"20","key":"2137_CR36","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","volume":"166","author":"DN Juurlink","year":"2006","unstructured":"Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE et al (2006) Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 166(20):2217\u20132221","journal-title":"Arch Intern Med"},{"issue":"5","key":"2137_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.vaccine.2010.09.020","volume":"29","author":"N Souayah","year":"2011","unstructured":"Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H et al (2011) Guillain-Barre syndrome after Gardasil vaccination: data from vaccine adverse event reporting system 2006\u20132009. Vaccine 29(5):886\u2013889","journal-title":"Vaccine"},{"issue":"12","key":"2137_CR38","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2105\/AJPH.87.12.2045","volume":"87","author":"J Tuttle","year":"1997","unstructured":"Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S (1997) The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 87(12):2045\u20132048","journal-title":"Am J Public Health"},{"key":"2137_CR39","unstructured":"Centers for Disease Control and Prevention (CDC. Update: Guillain-Barr\u00e9 syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006. MMWR. Morbidity and mortality weekly report. 2006 Oct 20;55(41):1120-4."},{"key":"2137_CR40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS (2021) Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. https:\/\/doi.org\/10.7759\/cureus.13426","journal-title":"Cureus"},{"issue":"5","key":"2137_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ncn3.12537","volume":"9","author":"J James","year":"2021","unstructured":"James J, Jose J, Gafoor VA, Smita B, Balaram N (2021) Guillain-Barre syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series. Neurol Clin Neurosci 9(5):402\u2013405","journal-title":"Neurol Clin Neurosci"},{"issue":"4","key":"2137_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956","volume":"14","author":"SU Patel","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B (2021) Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep 14(4):e242956","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2137_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/neurolint13030040","volume":"13","author":"A Prasad","year":"2021","unstructured":"Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S (2021) A Novel case of bifacial diplegia variant of guillain-barre syndrome following janssen covid-19 vaccination. Neurol Int 13(3):404\u2013409","journal-title":"Neurol Int"},{"issue":"11","key":"2137_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR et al (2019) Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat Rev Neurol 15(11):671\u2013683","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"2137_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR et al (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15(11):671\u2013683","journal-title":"Nat Rev Neurol"},{"issue":"88","key":"2137_CR46","first-page":"167","volume":"16","author":"TW West","year":"2013","unstructured":"West TW (2013) Transverse myelitis\u2013a review of the presentation, diagnosis, and initial management. Discov Med 16(88):167\u2013177","journal-title":"Discov Med"},{"issue":"8","key":"2137_CR47","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1007\/s00415-020-09934-w","volume":"267","author":"M Munz","year":"2020","unstructured":"Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Kramer S et al (2020) Acute transverse myelitis after COVID-19 pneumonia. J Neurol 267(8):2196\u20132197","journal-title":"J Neurol"},{"issue":"12","key":"2137_CR48","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s00415-020-09997-9","volume":"267","author":"A Zachariadis","year":"2020","unstructured":"Zachariadis A, Tulbu A, Strambo D, Dumoulin A, Di Virgilio G (2020) Transverse myelitis related to COVID-19 infection. J Neurol 267(12):3459\u20133461","journal-title":"J Neurol"},{"issue":"13","key":"2137_CR49","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/0961203309345730","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y (2009) Transverse myelitis and vaccines: a multi-analysis. Lupus 18(13):1198\u20131204","journal-title":"Lupus"},{"issue":"8","key":"2137_CR50","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/archneurol.2010.167","volume":"67","author":"W Akkad","year":"2010","unstructured":"Akkad W, Salem B, Freeman JW, Huntington MK (2010) Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine. Arch Neurol 67(8):1018\u20131020","journal-title":"Arch Neurol"},{"issue":"4","key":"2137_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1440-1754.2006.00840.x","volume":"42","author":"H Kelly","year":"2006","unstructured":"Kelly H (2006) Evidence for a causal association between oral polio vaccine and transverse myelitis: a case history and review of the Literature. J Paediatr Child Health 42(4):155\u2013159","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"2137_CR52","first-page":"430","volume":"31","author":"C Iniguez","year":"2000","unstructured":"Iniguez C, Mauri JA, Larrode P, Lopez del Val J, Jerico I, Morales F (2000) Acute transverse myelitis secondary to hepatitis B vaccination. Rev Neurol 31(5):430\u2013432","journal-title":"Rev Neurol"},{"issue":"7002","key":"2137_CR53","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/bmj.311.7002.422a","volume":"311","author":"KA Joyce","year":"1995","unstructured":"Joyce KA, Rees JE (1995) Transverse myelitis after measles, mumps, and rubella vaccine. BMJ 311(7002):422","journal-title":"BMJ"},{"issue":"8801","key":"2137_CR54","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)90703-6","volume":"339","author":"SJ Read","year":"1992","unstructured":"Read SJ, Schapel GJ, Pender MP (1992) Acute transverse myelitis after tetanus toxoid vaccination. Lancet 339(8801):1111\u20131112","journal-title":"Lancet"},{"issue":"10269","key":"2137_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397(10269):99\u2013111","journal-title":"Lancet"},{"issue":"6","key":"2137_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242344","volume":"14","author":"K Narasimhalu","year":"2021","unstructured":"Narasimhalu K, Lee WC, Salkade PR, De Silva DA (2021) Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19. BMJ Case Rep 14(6):e242344","journal-title":"BMJ Case Rep"},{"key":"2137_CR57","unstructured":"Evans SJW, Day SJ. Medicines and Healthcare Products Regulatory Agency (MHRA) (Formerly MCA). In: Armitage P, Colton T, editors. Encyclopedia of Biostatistics, 2005"},{"key":"2137_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577606","volume":"358","author":"C Pagenkopf","year":"2021","unstructured":"Pagenkopf C, Sudmeyer M (2021) A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 358:577606","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2137_CR59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218(3):e20202135","journal-title":"J Exp Med"},{"issue":"4","key":"2137_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1586\/eci.13.2","volume":"9","author":"O Vera-Lastra","year":"2013","unstructured":"Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Jara LJ, Shoenfeld Y (2013) Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol 9(4):361\u2013373","journal-title":"Expert Rev Clin Immunol"},{"key":"2137_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653786","volume":"12","author":"GC Roman","year":"2021","unstructured":"Roman GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D (2021) Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated atm and 3 post-vaccination atm serious adverse events with the chadox1 ncov-19 vaccine (AZD1222). Front Immunol 12:653786","journal-title":"Front Immunol"},{"issue":"1","key":"2137_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-13-1","volume":"13","author":"\u00c1C Calvo","year":"2013","unstructured":"Calvo \u00c1C, Mart\u00ednez MAM, Alentorn-Palau A, Escuer JB, Pinel LR, Mart\u00ednez-Y\u00e9lamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 13(1):1\u20138","journal-title":"BMC Neurol"},{"issue":"1","key":"2137_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ncl.2012.09.008","volume":"31","author":"SC Beh","year":"2013","unstructured":"Beh SC, Greenberg BM, Frohman T, Frohman EM (2013) Transverse myelitis. Neurol Clin 31(1):79\u2013138","journal-title":"Neurol Clin"},{"key":"2137_CR64","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823dc535","author":"T Scott","year":"2011","unstructured":"Scott T, Frohman E, De Seze J, Gronseth G, Weinshenker B (2011) Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e31823dc535","journal-title":"Neurology"},{"issue":"8","key":"2137_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236720","volume":"13","author":"CCN Chow","year":"2020","unstructured":"Chow CCN, Magnussen J, Ip J, Su Y (2020) Acute transverse myelitis in COVID-19 infection. BMJ Case Reports CP 13(8):e236720","journal-title":"BMJ Case Reports CP"},{"key":"2137_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102939","volume":"59","author":"S Shahjouei","year":"2020","unstructured":"Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G et al (2020) Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine 59:102939","journal-title":"EBioMedicine"},{"issue":"3","key":"2137_CR67","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","volume":"52","author":"AI Qureshi","year":"2021","unstructured":"Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Raju M et al (2021) Acute ischemic stroke and COVID-19: an analysis of 27 676 patients. Stroke 52(3):905\u2013912","journal-title":"Stroke"},{"issue":"2","key":"2137_CR68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1590\/1516-3180.2020.0659.r1.08122020","volume":"139","author":"ZB Gunduz","year":"2021","unstructured":"Gunduz ZB (2021) Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report. Sao Paulo Med J 139(2):190\u2013195","journal-title":"Sao Paulo Med J"},{"key":"2137_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327057","author":"HS Markus","year":"2021","unstructured":"Markus HS (2021) Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself. BMJ Publishing Group Ltd. https:\/\/doi.org\/10.1136\/jnnp-2021-327057","journal-title":"BMJ Publishing Group Ltd."},{"key":"2137_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2021.06.001","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Korn M (2021) Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages. https:\/\/doi.org\/10.1016\/j.hest.2021.06.001","journal-title":"Brain Hemorrhages"},{"key":"2137_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2273","author":"Z Mohseni Afshar","year":"2021","unstructured":"Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Saleki K, Barary M et al (2021) Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2273","journal-title":"Rev Med Virol"},{"issue":"6","key":"2137_CR72","first-page":"288","volume":"107","author":"H Mittelmeier","year":"1959","unstructured":"Mittelmeier H (1959) Generalized anaphylactic toxic blood vessel wall injury with sinus thrombosis after active diphtheria vaccination with a study on the etiology and pathogenesis of organic blood vessel diseases. Monatsschr Kinderheilkd 107(6):288\u2013293","journal-title":"Monatsschr Kinderheilkd"},{"issue":"3","key":"2137_CR73","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1651-2227.1993.tb12657.x","volume":"82","author":"U Nieminen","year":"1993","unstructured":"Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R (1993) Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr 82(3):267\u2013270","journal-title":"Acta Paediatr"},{"issue":"43","key":"2137_CR74","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1016\/j.vaccine.2017.08.086","volume":"35","author":"ER Vickers","year":"2017","unstructured":"Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM et al (2017) Risk of venous thromboembolism following influenza vaccination in adults aged 50 years and older in the vaccine safety datalink. Vaccine 35(43):5872\u20135877","journal-title":"Vaccine"},{"key":"2137_CR75","doi-asserted-by":"publisher","DOI":"10.1055\/a-1469-7481","author":"J Oldenburg","year":"2021","unstructured":"Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C et al (2021) Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie. https:\/\/doi.org\/10.1055\/a-1469-7481","journal-title":"Hamostaseologie"},{"issue":"24","key":"2137_CR76","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2021.7517","volume":"325","author":"I See","year":"2021","unstructured":"See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT et al (2021) 2021 US case reports of cerebral venous sinus Thrombosis with Thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21. JAMA 325(24):2448\u20132456","journal-title":"JAMA"},{"key":"2137_CR77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2105869","author":"KL Muir","year":"2021","unstructured":"Muir KL, Kallam A, Koepsell SA, Gundabolu K (2021) Thrombotic Thrombocytopenia after Ad26.COV.2S Vaccination. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2105869","journal-title":"N Engl J Med"},{"issue":"7","key":"2137_CR78","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/jth.15347","volume":"19","author":"RA Blauenfeldt","year":"2021","unstructured":"Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM (2021) Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost 19(7):1771\u20131775","journal-title":"J Thromb Haemost"},{"key":"2137_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-326984","author":"T Al-Mayhani","year":"2021","unstructured":"Al-Mayhani T, Saber S, Stubbs MJ, Losseff NA, Perry RJ, Simister RJ et al (2021) Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2021-326984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2137_CR80","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","volume":"95","author":"PR Mehta","year":"2021","unstructured":"Mehta PR, Apap Mangion S, Benger M, Stanton BR, Czuprynska J, Arya R et al (2021) Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases. Brain Behav Immun 95:514\u2013517","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2137_CR81","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/jcm10081599","volume":"10","author":"ME Wolf","year":"2021","unstructured":"Wolf ME, Luz B, Niehaus L, Bhogal P, B\u00e4zner H, Henkes H (2021) Thrombocytopenia and intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure. J Clin Med 10(8):1599","journal-title":"J Clin Med"},{"issue":"22","key":"2137_CR82","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT et al (2021) Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(22):2124\u20132130","journal-title":"N Engl J Med"},{"key":"2137_CR83","unstructured":"Bj\u00f8rnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskr Nor Laegeforen. 2021 Apr 29;141."},{"issue":"16","key":"2137_CR84","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/CIRCULATIONAHA.108.780759","volume":"118","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, Brouwer J-LP, Veeger NJ, van der Meer J (2008) Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 118(16):1659\u20131667","journal-title":"Circulation"},{"issue":"1","key":"2137_CR85","first-page":"56","volume":"108","author":"EL Simpson","year":"2001","unstructured":"Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD (2001) Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 108(1):56\u201360","journal-title":"BJOG"},{"issue":"4","key":"2137_CR86","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.mbc.0000224845.27378.c3","volume":"17","author":"J Lin","year":"2006","unstructured":"Lin J, Wakefield TW, Henke PK (2006) Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis 17(4):265\u2013270","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2137_CR87","doi-asserted-by":"crossref","unstructured":"Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost. 2006;32(7):651-8.","DOI":"10.1055\/s-2006-951293"},{"issue":"4","key":"2137_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.06.021","volume":"15","author":"A Dutta","year":"2021","unstructured":"Dutta A, Ghosh R, Bhattacharya D, Bhat S, Ray A, Pandit A et al (2021) Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes Metab Syndr 15(4):102184","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"2137_CR89","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13760-018-1009-6","volume":"120","author":"B Shakibajahromi","year":"2020","unstructured":"Shakibajahromi B, Haghighi AB, Salehi A, Vardanjani HM, Ghaedian M, Safari A et al (2020) Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg 120(4):845\u2013852","journal-title":"Acta Neurol Belg"},{"key":"2137_CR90","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.88a.ccc078","author":"KR McCrae","year":"2021","unstructured":"McCrae KR (2021) Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination. Cleveland Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.88a.ccc078","journal-title":"Cleveland Clin J Med"},{"issue":"23","key":"2137_CR91","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M et al (2021) Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(23):2202\u20132211","journal-title":"N Engl J Med"},{"key":"2137_CR92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2106315","author":"DB Cines","year":"2021","unstructured":"Cines DB, Bussel JB (2021) SARS-CoV-2 vaccine\u2013induced immune thrombotic thrombocytopenia. Mass Medical Soc. https:\/\/doi.org\/10.1056\/NEJMe2106315","journal-title":"Mass Medical Soc"},{"issue":"3","key":"2137_CR93","volume":"12","author":"A Filatov","year":"2020","unstructured":"Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 12(3):e7352","journal-title":"Cureus"},{"key":"2137_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106839","volume":"208","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, Janes F, Gigli GL, Curcio F, Negro ID, D\u2019Agostini S et al (2021) Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 208:106839","journal-title":"Clin Neurol Neurosurg"},{"key":"2137_CR95","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001080","author":"GS Manzano","year":"2021","unstructured":"Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK (2021) Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following covid-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001080","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"2137_CR96","first-page":"E82","volume":"41","author":"PS Utukuri","year":"2020","unstructured":"Utukuri PS, Bautista A, Lignelli A, Moonis G (2020) Possible acute disseminated encephalomyelitis related to severe acute respiratory syndrome coronavirus 2 infection. AJNR Am J Neuroradiol 41(9):E82\u2013E83","journal-title":"AJNR Am J Neuroradiol"},{"key":"2137_CR97","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16172","author":"BD Liu","year":"2021","unstructured":"Liu BD, Ugolini C, Jha P (2021) Two cases of post-moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus. Cureus. https:\/\/doi.org\/10.7759\/cureus.16172","journal-title":"Cureus"},{"key":"2137_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01608-2","author":"L Cao","year":"2021","unstructured":"Cao L, Ren L (2021) Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg. https:\/\/doi.org\/10.1007\/s13760-021-01608-2","journal-title":"Acta Neurol Belg"},{"key":"2137_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01855-3","author":"GO Kenangil","year":"2021","unstructured":"Kenangil GO, Ari BC, Guler C, Demir MK (2021) Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg. https:\/\/doi.org\/10.1007\/s13760-021-01855-3","journal-title":"Acta Neurol Belg"},{"issue":"03","key":"2137_CR100","first-page":"31","volume":"1","author":"M Raknuzzaman","year":"2021","unstructured":"Raknuzzaman M, Jannaty T, Hossain MB, Saha B, Dey SK, Shahidullah M (2021) Post covid19 vaccination acute disseminated encephalomyelitis: a case report in bangladesh. Int J Med Sci Clin Res Stud 1(03):31\u201336","journal-title":"Int J Med Sci Clin Res Stud"},{"issue":"4","key":"2137_CR101","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1542\/peds.1.4.437","volume":"1","author":"RK Byers","year":"1948","unstructured":"Byers RK, Moll FC (1948) Encephalopathies following prophylactic pertussis vaccine. Pediatrics 1(4):437\u2013457","journal-title":"Pediatrics"},{"issue":"3","key":"2137_CR102","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1542\/peds.101.3.383","volume":"101","author":"RE Weibel","year":"1998","unstructured":"Weibel RE, Caserta V, Benor DE, Evans G (1998) Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National vaccine injury compensation program. Pediatrics 101(3):383\u2013387","journal-title":"Pediatrics"},{"key":"2137_CR103","unstructured":"Souayah S, Thepmankorn P, Jedidi N, Nasar A, Souayah N. Encephalopathy after Gardasil Vaccination: A Vaccine Adverse Event Reporting System Study 2006\u20132019 (3038). Neurology. 2021;96(15 Supplement):3038."},{"key":"2137_CR104","doi-asserted-by":"crossref","unstructured":"Sugaya N. Influenza-associated encephalopathy in Japan. Semin Pediatr Infect Dis. 2002;13(2):79-84.","DOI":"10.1053\/spid.2002.122993"},{"issue":"24","key":"2137_CR105","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1212\/WNL.0b013e3182020307","volume":"75","author":"JT Denholm","year":"2010","unstructured":"Denholm JT, Neal A, Yan B, Petty S, Knox J, French C et al (2010) Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination. Neurology 75(24):2246\u20132248","journal-title":"Neurology"},{"key":"2137_CR106","doi-asserted-by":"crossref","unstructured":"Cavanagh L, Strutt AM, Schulz PE. Acute Demyelinating Encephalomyelitis (ADEM) following rabies vaccination. International Journal of Case Reports. 2021 Jun 18;5:206-206.","DOI":"10.28933\/ijcr-2021-03-1305"},{"issue":"2","key":"2137_CR107","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1212\/WNL.53.2.396","volume":"53","author":"A Tourbah","year":"1999","unstructured":"Tourbah A, Gout O, Liblau R, Lyon-Caen O, Bougniot C, Iba-Zizen MT et al (1999) Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 53(2):396\u2013401","journal-title":"Neurology"},{"key":"2137_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577661","volume":"358","author":"L Baldelli","year":"2021","unstructured":"Baldelli L, Amore G, Montini A, Panzera I, Rossi S, Cortelli P et al (2021) Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine. J Neuroimmunol 358:577661","journal-title":"J Neuroimmunol"},{"key":"2137_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.621773","volume":"11","author":"Y Alnefeesi","year":"2020","unstructured":"Alnefeesi Y, Siegel A, Lui LMW, Teopiz KM, Ho RCM, Lee Y et al (2020) Impact of SARS-CoV-2 infection on cognitive function: a systematic review. Front Psychiatry 11:621773","journal-title":"Front Psychiatry"},{"key":"2137_CR110","doi-asserted-by":"crossref","unstructured":"Chahil M, Pillainayagam C, Schulz P. Treatment of Post-Influenza Vaccination Induced Acute Disseminated Encephalomyelitis (ADEM) with Plasma Exchange - A Case Report (P4.036). Neurology. 2014;82(10 Supplement):P4.036","DOI":"10.1212\/WNL.82.10_supplement.P4.036"},{"key":"2137_CR111","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.msard.2017.09.018","volume":"18","author":"M Iype","year":"2017","unstructured":"Iype M, Kunju PAM, Saradakutty G, Anish TS, Sreedharan M, Ahamed SM (2017) Short term outcome of ADEM: results from a retrospective cohort study from South India. Mult Scler Relat Disord 18:128\u2013134","journal-title":"Mult Scler Relat Disord"},{"issue":"Suppl 1","key":"2137_CR112","first-page":"557","volume":"11","author":"S Ebrahimpour","year":"2020","unstructured":"Ebrahimpour S, Mohseni Afshar Z, Mohseni S, Masrour-Roudsari J, Oladzade S, Bayani M et al (2020) Neurologic manifestations in patients with COVID-19: a case report. Caspian J Intern Med 11(Suppl 1):557\u2013560","journal-title":"Caspian J Intern Med"},{"key":"2137_CR113","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15603","author":"MB Habib","year":"2021","unstructured":"Habib MB, Hamad MK, Kalash T, Ahmed A, Mohamed MF (2021) COVID-19 Pneumonia complicated by seizure due to severe hyponatremia. Cureus. https:\/\/doi.org\/10.7759\/cureus.15603","journal-title":"Cureus"},{"key":"2137_CR114","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10072-020-04460-z","volume":"41","author":"A Fasano","year":"2020","unstructured":"Fasano A, Cavallieri F, Canali E, Valzania F (2020) First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci 41:1651\u20131653","journal-title":"Neurol Sci"},{"issue":"43","key":"2137_CR115","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1016\/j.vaccine.2020.08.044","volume":"38","author":"RL Marchetti","year":"2020","unstructured":"Marchetti RL, Gallucci-Neto J, Kurcgant D, Proen\u00e7a ICGF, Valiengo LdCL, Fiore LA et al (2020) Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco. Brazil. Vaccine. 38(43):6714\u20136720","journal-title":"Brazil. Vaccine."},{"issue":"3","key":"2137_CR116","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1176\/jnp.23.3.jnpe37","volume":"23","author":"CY Lin","year":"2011","unstructured":"Lin CY, Peng CC, Liu HC, Chiu NC (2011) Psychogenic movement disorder after H1N1 influenza vaccination. J Neuropsychiatry Clin Neurosci 23(3):E37\u2013E38","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"31","key":"2137_CR117","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1016\/j.vaccine.2015.06.009","volume":"33","author":"SJ Ma","year":"2015","unstructured":"Ma SJ, Xiong YQ, Jiang LN, Chen Q (2015) Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: a systematic review and meta-analysis. Vaccine 33(31):3636\u20133649","journal-title":"Vaccine"},{"issue":"3","key":"2137_CR118","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.dsx.2021.05.003","volume":"15","author":"R Ghosh","year":"2021","unstructured":"Ghosh R, Dubey S, Roy D, Mandal A, Naga D, Benito-Leon J (2021) Focal onset non-motor seizure following COVID-19 vaccination: a mere coincidence? Diabetes Metab Syndr 15(3):1023\u20131024","journal-title":"Diabetes Metab Syndr"},{"key":"2137_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577629","volume":"357","author":"Y Aladdin","year":"2021","unstructured":"Aladdin Y, Shirah B (2021) New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. J Neuroimmunol 357:577629","journal-title":"J Neuroimmunol"},{"issue":"24","key":"2137_CR120","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1001\/jama.2016.18625","volume":"316","author":"JR Gavvala","year":"2016","unstructured":"Gavvala JR, Schuele SU (2016) New-onset seizure in adults and adolescents: a review. JAMA 316(24):2657\u20132668","journal-title":"JAMA"},{"issue":"6","key":"2137_CR121","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1684\/ejd.2020.3924","volume":"30","author":"L Brambilla","year":"2020","unstructured":"Brambilla L, Maronese CA, Tourlaki A, Veraldi S (2020) Herpes zoster following COVID-19: a report of three cases. Eur J Dermatol 30(6):754\u2013756","journal-title":"Eur J Dermatol"},{"issue":"7","key":"2137_CR122","volume":"12","author":"A Saati","year":"2020","unstructured":"Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M (2020) Herpes Zoster co-Infection in an immunocompetent patient with COVID-19. Cureus 12(7):e8998","journal-title":"Cureus"},{"issue":"8","key":"2137_CR123","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/ijd.15001","volume":"59","author":"F Tartari","year":"2020","unstructured":"Tartari F, Spadotto A, Zengarini C, Zanoni R, Guglielmo A, Adorno A et al (2020) Herpes zoster in COVID-19-positive patients. Int J Dermatol 59(8):1028\u20131029","journal-title":"Int J Dermatol"},{"issue":"9","key":"2137_CR124","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/00007890-199505150-00020","volume":"59","author":"H Ruder","year":"1995","unstructured":"Ruder H, Kerling F, Daniel V, Korn K, Wassmuth R (1995) Decreased alloreactivity after vaccination against hepatitis B. Transplantation 59(9):1339\u20131342","journal-title":"Transplantation"},{"issue":"6","key":"2137_CR125","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jocd.14035","volume":"20","author":"E Bostan","year":"2021","unstructured":"Bostan E, Yalici-Armagan B (2021) Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol 20(6):1566\u20131567","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"2137_CR126","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1708-8305.2006.00098.x","volume":"14","author":"JM Bayas","year":"2007","unstructured":"Bayas JM, Gonzalez-Alvarez R, Guinovart C (2007) Herpes zoster after yellow fever vaccination. J Travel Med 14(1):65\u201366","journal-title":"J Travel Med"},{"issue":"9155","key":"2137_CR127","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","volume":"353","author":"R Walter","year":"1999","unstructured":"Walter R, Hartmann K, Fleisch F, Reinhart WH, Kuhn M (1999) Reactivation of herpesvirus infections after vaccinations? Lancet 353(9155):810","journal-title":"Lancet"},{"key":"2137_CR128","doi-asserted-by":"crossref","unstructured":"Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford, England). 2021","DOI":"10.1093\/rheumatology\/keab345"},{"key":"2137_CR129","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijid.2021.08.048","volume":"111","author":"CS van Dam","year":"2021","unstructured":"van Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rosken R, Smits M (2021) Herpes zoster after COVID vaccination. Int J Infect Dis 111:169\u2013171","journal-title":"Int J Infect Dis"},{"key":"2137_CR130","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdcr.2021.05.042","volume":"15","author":"L Channa","year":"2021","unstructured":"Channa L, Torre K, Rothe M (2021) Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination. JAAD Case Rep 15:60\u201361","journal-title":"JAAD Case Rep"},{"key":"2137_CR131","doi-asserted-by":"crossref","unstructured":"Vastarella M, Picone V, Martora F, Fabbrocini G. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e845-e846.","DOI":"10.1111\/jdv.17576"},{"key":"2137_CR132","doi-asserted-by":"crossref","unstructured":"Arora P, Sardana K, Mathachan SR, Malhotra P. Herpes zoster after inactivated COVID-19 vaccine: A cutaneous adverse effect of the vaccine. J Cosmet Dermatol. 2021 Nov;20(11):3389-3390.","DOI":"10.1111\/jocd.14268"},{"key":"2137_CR133","doi-asserted-by":"crossref","unstructured":"Chiu HH, Wei KC, Chen A, Wang WH. Herpes zoster following COVID-19 vaccine: A report of three cases. QJM: An International Journal of Medicine. 2021 Jul;114(7):531-2.","DOI":"10.1093\/qjmed\/hcab208"},{"issue":"11","key":"2137_CR134","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1111\/jdv.17550","volume":"35","author":"F Nastro","year":"2021","unstructured":"Nastro F, Fabbrocini G, di Vico F, Marasca C (2021) Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 35(11):e745\u2013e747","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2137_CR135","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI (2013) Clinical practice: Herpes zoster. N Engl J Med 369(3):255\u2013263","journal-title":"N Engl J Med"},{"key":"2137_CR136","doi-asserted-by":"crossref","unstructured":"Li X, Ostropolets A, Makadia R, Shaoibi A, Rao G, Sena AG, et al. 2021 Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. medRxiv. 22: 553","DOI":"10.1101\/2021.03.25.21254315"},{"issue":"6","key":"2137_CR137","volume":"13","author":"AR Tagliaferri","year":"2021","unstructured":"Tagliaferri AR, Narvaneni S, Azzam MH, Grist W (2021) A case of COVID-19 vaccine causing a myasthenia gravis crisis. Cureus 13(6):e15581","journal-title":"Cureus"},{"key":"2137_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.02.011","author":"M Alfishawy","year":"2021","unstructured":"Alfishawy M, Bitar Z, Elgazzar A, Elzoueiry M (2021) Neuroleptic malignant syndrome following COVID-19 vaccination. Am J Emerg Med. https:\/\/doi.org\/10.1016\/j.ajem.2021.02.011","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2137_CR139","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.27251","volume":"64","author":"W Waheed","year":"2021","unstructured":"Waheed W, Carey ME, Tandan SR, Tandan R (2021) Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve 64(1):E1\u2013E2","journal-title":"Muscle Nerve"},{"issue":"1","key":"2137_CR140","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","volume":"22","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC et al (2022) Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis 22(1):64\u201372","journal-title":"Lancet Infect Dis"},{"key":"2137_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.820723","volume":"12","author":"JE Kim","year":"2021","unstructured":"Kim JE, Min YG, Shin JY, Kwon YN, Bae JS, Sung JJ et al (2021) Guillain-Barr\u00e9 Syndrome and variants following covid-19 vaccination: report of 13 cases. Front Neurol 12:820723","journal-title":"Front Neurol"},{"issue":"3","key":"2137_CR142","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00415-021-10785-2","volume":"269","author":"E Khan","year":"2022","unstructured":"Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S (2022) Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. J Neurol 269(3):1121\u20131132","journal-title":"J Neurol"},{"key":"2137_CR143","unstructured":"Huang YJ, Huang CS. 2022 Postvaccinal Encephalopathy Presenting with Amnesia and Seizure After ChAdOx1 nCov-19 Vaccination: A Case Report. Acta Neurol Taiwan"},{"issue":"5","key":"2137_CR144","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2022.30","volume":"36","author":"ZM Afshar","year":"2021","unstructured":"Afshar ZM, Babazadeh A, Afsharian M, Vaziri S, Ebrahimpour S (2021) Bell\u2019s palsy associated with covid-19 infection: a case report. Oman Med J 36(5):e313","journal-title":"Oman Med J"},{"issue":"1","key":"2137_CR145","doi-asserted-by":"publisher","first-page":"e240095","DOI":"10.1136\/bcr-2020-240095","volume":"14","author":"EH Dahl","year":"2021","unstructured":"Dahl EH, Mosevoll KA, Cramariuc D, Vedeler CA, Blomberg B (2021) COVID-19 myocarditis and postinfection Bell\u2019s palsy. BMJ Case Rep 14(1):e240095","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2137_CR146","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ccr3.3631","volume":"9","author":"A Bastola","year":"2021","unstructured":"Bastola A, Sah R, Nepal G, Gajurel BP, Rajbhandari SK, Chalise BS et al (2021) Bell\u2019s palsy as a possible neurological complication of COVID-19: a case report. Clin Case Rep 9(2):747\u2013750","journal-title":"Clin Case Rep"},{"issue":"9","key":"2137_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4801","volume":"9","author":"AF Al-Mashdali","year":"2021","unstructured":"Al-Mashdali AF, Al Samawi MS (2021) A case of post COVID-19 multisystem inflammatory syndrome and Bell\u2019s palsy in a young adult. Clin Case Rep 9(9):e04801","journal-title":"Clin Case Rep"},{"key":"2137_CR148","first-page":"5569841","volume":"2021","author":"M Hasibi","year":"2021","unstructured":"Hasibi M, Seyed Ahadi M, Abdollahi H, Jafari M (2021) Protracted COVID-19 during treatment of facial palsy. Case Rep Neurol Med 2021:5569841","journal-title":"Case Rep Neurol Med"},{"issue":"1","key":"2137_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2021.101600","volume":"65","author":"EF Ferreira","year":"2022","unstructured":"Ferreira EF, Portugal D, Silva N, Peixoto C, Matos C, Pereira I et al (2022) Rehabilitation of peripheral facial palsy associated with COVID-19 in a child: a case report. Ann Phys Rehabil Med 65(1):101600","journal-title":"Ann Phys Rehabil Med"},{"issue":"1","key":"2137_CR150","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13052-022-01263-0","volume":"48","author":"A Iacono","year":"2022","unstructured":"Iacono A, Pennisi E, Benincasa C, Marchetti F (2022) A case of facial nerve palsy in a pediatric patient associated with Covid-19. Ital J Pediatr 48(1):75","journal-title":"Ital J Pediatr"},{"issue":"4","key":"2137_CR151","volume":"13","author":"AC Kaplan","year":"2021","unstructured":"Kaplan AC (2021) Noteworthy neurological manifestations associated with covid-19 infection. Cureus 13(4):e14391","journal-title":"Cureus"},{"issue":"11","key":"2137_CR152","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/healthcare9111492","volume":"9","author":"AK Szewczyk","year":"2021","unstructured":"Szewczyk AK, Skrobas U, Jamroz-Wisniewska A, Mitosek-Szewczyk K, Rejdak K (2021) Facial diplegia-complication or manifestation of SARS-cov-2 Infection? a Case report and systemic literature review. Healthcare (Basel). 9(11):1492","journal-title":"Healthcare (Basel)."},{"issue":"3","key":"2137_CR153","doi-asserted-by":"publisher","first-page":"e240267","DOI":"10.1136\/bcr-2020-240267","volume":"14","author":"V Kumar","year":"2021","unstructured":"Kumar V, Narayanan P, Shetty S, Mohammed AP (2021) Lower motor neuron facial palsy in a postnatal mother with COVID-19. BMJ Case Rep 14(3):e240267","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2137_CR154","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ccr3.3716","volume":"9","author":"WL Neo","year":"2021","unstructured":"Neo WL, Ng JCF, Iyer NG (2021) The great pretender-Bell\u2019s palsy secondary to SARS-CoV-2? Clin Case Rep 9(3):1175\u20131177","journal-title":"Clin Case Rep"},{"key":"2137_CR155","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.927956","volume":"21","author":"M Khaja","year":"2020","unstructured":"Khaja M, Gomez GPR, Santana Y, Hernandez N, Haider A, Lara JLP et al (2020) A 44-year-old Hispanic man with loss of taste and bilateral facial weakness diagnosed with Guillain-Barre syndrome and bell\u2019s palsy associated with sars-cov-2 infection treated with intravenous immunoglobulin. Am J Case Rep 21:e927956","journal-title":"Am J Case Rep"},{"issue":"2","key":"2137_CR156","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.braindev.2020.08.017","volume":"43","author":"C Theophanous","year":"2021","unstructured":"Theophanous C, Santoro JD, Itani R (2021) Bell\u2019s palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Brain Dev 43(2):357\u2013359","journal-title":"Brain Dev"},{"key":"2137_CR157","doi-asserted-by":"publisher","unstructured":"Yue Wan, Shugang Cao, Qi Fang et al. Coronavirus disease 2019 complicated with Bell\u2019s palsy: a case report, 16 April 2020, PREPRINT (Version 1) available at Research Square [https:\/\/doi.org\/10.21203\/rs.3.rs-23216\/v1]","DOI":"10.21203\/rs.3.rs-23216\/v1"},{"issue":"4","key":"2137_CR158","first-page":"609","volume":"29","author":"N Bohania","year":"2021","unstructured":"Bohania N, Ish P, Nune A, Iyengar KP (2021) Cranial neuropathy in COVID-19: a case series and review of literature. Infez Med 29(4):609\u2013613","journal-title":"Infez Med"},{"issue":"7","key":"2137_CR159","doi-asserted-by":"publisher","first-page":"e243829","DOI":"10.1136\/bcr-2021-243829","volume":"14","author":"A Burrows","year":"2021","unstructured":"Burrows A, Bartholomew T, Rudd J, Walker D (2021) Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Rep 14(7):e243829","journal-title":"BMJ Case Rep"},{"key":"2137_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2021.10.010","volume":"82","author":"M Cellina","year":"2022","unstructured":"Cellina M, D\u2019Arrigo A, Floridi C, Oliva G, Carrafiello G (2022) Left Bell\u2019s palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: a case report. Clin Imaging 82:1\u20134","journal-title":"Clin Imaging"},{"key":"2137_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101259","volume":"25","author":"CC Mussatto","year":"2022","unstructured":"Mussatto CC, Sokol J, Alapati N (2022) Bell\u2019s palsy following COVID-19 vaccine administration in HIV+ patient. Am J Ophthalmol Case Rep 25:101259","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"27","key":"2137_CR162","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.12998\/wjcc.v9.i27.8274","volume":"9","author":"BY Yu","year":"2021","unstructured":"Yu BY, Cen LS, Chen T, Yang TH (2021) Bell\u2019s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy: a case report. World J Clin Cases 9(27):8274\u20138279","journal-title":"World J Clin Cases"},{"issue":"8","key":"2137_CR163","volume":"13","author":"MC Mason","year":"2021","unstructured":"Mason MC, Liaqat A, Morrow J, Basso R, Gujrati Y (2021) Bilateral facial nerve palsy and covid-19 vaccination: causation or coincidence? Cureus 13(8):e17602","journal-title":"Cureus"},{"issue":"2","key":"2137_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5468","volume":"10","author":"O Mirmosayyeb","year":"2022","unstructured":"Mirmosayyeb O, Barzegar M, Rezaei M, Baharlouie N, Shaygannejad V (2022) Bell\u2019s palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination. Clin Case Rep 10(2):e05468","journal-title":"Clin Case Rep"},{"issue":"2","key":"2137_CR165","first-page":"298","volume":"28","author":"S Pothiawala","year":"2021","unstructured":"Pothiawala S (2021) Bell\u2019s palsy after second dose of moderna covid-19 vaccine: coincidence or causation? Acta Med Litu 28(2):298\u2013301","journal-title":"Acta Med Litu"},{"issue":"3","key":"2137_CR166","first-page":"e23195","volume":"14","author":"M Kundi","year":"2022","unstructured":"Kundi M, Montgomery S, Mao S, Asghar S (2022) Not all that is droopy post ad26cov2s (jnj) vaccine is bell\u2019s palsy: a rare case of isolated dorsal pontine stroke causing ipsilateral complete hemi-facial palsy. Cureus. 14(3):e23195","journal-title":"Cureus."},{"issue":"9","key":"2137_CR167","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/hcab143","volume":"114","author":"Y Nishizawa","year":"2021","unstructured":"Nishizawa Y, Hoshina Y, Baker V (2021) Bell\u2019s palsy following the Ad26.COV2.S COVID-19 vaccination. QJM 114(9):657\u2013658","journal-title":"QJM"},{"issue":"1","key":"2137_CR168","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-021-10617-3","volume":"269","author":"C Martin-Villares","year":"2022","unstructured":"Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno MJ, de la Nogal-Fernandez B (2022) Bell\u2019s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. J Neurol 269(1):47\u201348","journal-title":"J Neurol"},{"issue":"2","key":"2137_CR169","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jns.12382","volume":"25","author":"E Scheidl","year":"2020","unstructured":"Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B (2020) Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst 25(2):204\u2013207","journal-title":"J Peripher Nerv Syst"},{"key":"2137_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106413","volume":"200","author":"T Bueso","year":"2021","unstructured":"Bueso T, Montalvan V, Lee J, Gomez J, Ball S, Shoustari A et al (2021) Guillain-Barre Syndrome and COVID-19: a case report. Clin Neurol Neurosurg 200:106413","journal-title":"Clin Neurol Neurosurg"},{"key":"2137_CR171","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235","journal-title":"J Clin Neurosci"},{"issue":"2","key":"2137_CR172","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","volume":"42","author":"E Agosti","year":"2021","unstructured":"Agosti E, Giorgianni A, D\u2019Amore F, Vinacci G, Balbi S, Locatelli D (2021) Is Guillain-Barre syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci 42(2):607\u2013612","journal-title":"Neurol Sci"},{"issue":"4","key":"2137_CR173","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/NRL.0000000000000291","volume":"25","author":"S Paybast","year":"2020","unstructured":"Paybast S, Gorji R, Mavandadi S (2020) Guillain-Barre syndrome as a neurological complication of novel covid-19 infection: a case report and review of the literature. Neurologist 25(4):101\u2013103","journal-title":"Neurologist"},{"key":"2137_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100203","volume":"12","author":"C Dufour","year":"2021","unstructured":"Dufour C, Co TK, Liu A (2021) GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - a case report, systemic review and implication for vaccine development. Brain Behav Immun Health 12:100203","journal-title":"Brain Behav Immun Health"},{"issue":"26","key":"2137_CR175","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG et al (2020) Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med 382(26):2574\u20132576","journal-title":"N Engl J Med"},{"issue":"6","key":"2137_CR176","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","volume":"176","author":"H El Otmani","year":"2020","unstructured":"El Otmani H, El Moutawakil B, Rafai MA, El Benna N, El Kettani C, Soussi M et al (2020) Covid-19 and Guillain-Barre syndrome: more than a coincidence! Rev Neurol (Paris) 176(6):518\u2013519","journal-title":"Rev Neurol (Paris)"},{"issue":"10","key":"2137_CR177","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","volume":"93","author":"F Khan","year":"2021","unstructured":"Khan F, Sharma P, Pandey S, Sharma D, V V, Kumar N, et al (2021) COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? J Med Virol 93(10):6045\u20136049","journal-title":"J Med Virol"},{"issue":"2","key":"2137_CR178","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.1002\/mus.26988","volume":"62","author":"XW Su","year":"2020","unstructured":"Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F (2020) SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia. Muscle Nerve 62(2):E48\u2013E49","journal-title":"Muscle Nerve"},{"key":"2137_CR179","doi-asserted-by":"publisher","DOI":"10.4081\/ejtm.2021.9494","author":"M Darvishi","year":"2021","unstructured":"Darvishi M, Shahali H, Farahani AA (2021) Guillain-Barre syndrome associated with sars-cov-2 infection: a case report. Eur J Transl Myol. https:\/\/doi.org\/10.4081\/ejtm.2021.9494","journal-title":"Eur J Transl Myol"},{"issue":"5","key":"2137_CR180","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19(5):383\u2013384","journal-title":"Lancet Neurol"},{"issue":"1","key":"2137_CR181","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12883-021-02162-3","volume":"21","author":"N Mackenzie","year":"2021","unstructured":"Mackenzie N, Lopez-Coronel E, Dau A, Maloof D, Mattar S, Garcia JT et al (2021) Concomitant Guillain-Barre syndrome with COVID-19: a case report. BMC Neurol 21(1):135","journal-title":"BMC Neurol"},{"issue":"3","key":"2137_CR182","doi-asserted-by":"publisher","first-page":"198","DOI":"10.12691\/ajmcr-9-3-16","volume":"9","author":"Z Mostel","year":"2021","unstructured":"Mostel Z, Ayat P, Capric V, Trimmingham A, McFarlane SI (2021) Guillain-Barre syndrome in a covid-19 patient: a case report and review of management strategies. Am J Med Case Rep 9(3):198\u2013200","journal-title":"Am J Med Case Rep"},{"key":"2137_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577294","volume":"346","author":"MA Farzi","year":"2020","unstructured":"Farzi MA, Ayromlou H, Jahanbakhsh N, Bavil PH, Janzadeh A, Shayan FK (2020) Guillain-Barre syndrome in a patient infected with SARS-CoV-2, a case report. J Neuroimmunol 346:577294","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2137_CR184","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s13365-021-00984-y","volume":"27","author":"JH Nejad","year":"2021","unstructured":"Nejad JH, Heiat M, Hosseini MJ, Allahyari F, Lashkari A, Torabi R et al (2021) Guillain-Barre syndrome associated with COVID-19: a case report study. J Neurovirol 27(5):802\u2013805","journal-title":"J Neurovirol"},{"issue":"7","key":"2137_CR185","doi-asserted-by":"publisher","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","volume":"14","author":"N McKean","year":"2021","unstructured":"McKean N, Chircop C (2021) Guillain-Barre syndrome after COVID-19 vaccination. BMJ Case Rep 14(7):e244125","journal-title":"BMJ Case Rep"},{"issue":"6","key":"2137_CR186","doi-asserted-by":"publisher","first-page":"e243629","DOI":"10.1136\/bcr-2021-243629","volume":"14","author":"T Hasan","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G (2021) Case of Guillain-Barre syndrome following COVID-19 vaccine. BMJ Case Rep 14(6):e243629","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2137_CR187","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","volume":"90","author":"CM Allen","year":"2021","unstructured":"Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R et al (2021) Guillain-Barre syndrome variant occurring after sars-cov-2 vaccination. Ann Neurol 90(2):315\u2013318","journal-title":"Ann Neurol"},{"key":"2137_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577691","volume":"359","author":"YG Min","year":"2021","unstructured":"Min YG, Ju W, Ha YE, Ban JJ, Lee SA, Sung JJ et al (2021) Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature. J Neuroimmunol 359:577691","journal-title":"J Neuroimmunol"},{"issue":"11","key":"2137_CR189","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1080\/21645515.2021.1954826","volume":"17","author":"R Scendoni","year":"2021","unstructured":"Scendoni R, Petrelli C, Scaloni G, Logullo FO (2021) Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccin Immunother 17(11):4093\u20134096","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"2137_CR190","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.26143","volume":"90","author":"BV Maramattom","year":"2021","unstructured":"Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA et al (2021) Guillain-Barre Syndrome following ChAdOx1-S\/nCoV-19 Vaccine. Ann Neurol 90(2):312\u2013314","journal-title":"Ann Neurol"},{"key":"2137_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106887","volume":"208","author":"A Introna","year":"2021","unstructured":"Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM et al (2021) Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association? Clin Neurol Neurosurg 208:106887","journal-title":"Clin Neurol Neurosurg"},{"key":"2137_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102540","volume":"67","author":"A Razok","year":"2021","unstructured":"Razok A, Shams A, Almeer A, Zahid M (2021) Post-COVID-19 vaccine Guillain-Barre syndrome; first reported case from Qatar. Ann Med Surg (Lond) 67:102540","journal-title":"Ann Med Surg (Lond)"},{"issue":"5","key":"2137_CR193","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/20009666.2021.1954284","volume":"11","author":"SJ Rao","year":"2021","unstructured":"Rao SJ, Khurana S, Murthy G, Dawson ET, Jazebi N, Haas CJ (2021) A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine. J Community Hosp Intern Med Perspect 11(5):597\u2013600","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2137_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577523","volume":"353","author":"MC Moreno-Escobar","year":"2021","unstructured":"Moreno-Escobar MC, Kataria S, Khan E, Subedi R, Tandon M, Peshwe K et al (2021) Acute transverse myelitis with dysautonomia following sars-cov-2 infection: a case report and review of literature. J Neuroimmunol 353:577523","journal-title":"J Neuroimmunol"},{"issue":"12","key":"2137_CR195","volume":"13","author":"R Qazi","year":"2021","unstructured":"Qazi R, Memon A, Mohamed AS, Ali M, Singh R (2021) Post-COVID-19 acute transverse myelitis: a case report and literature review. Cureus 13(12):e20628","journal-title":"Cureus"},{"key":"2137_CR196","doi-asserted-by":"crossref","unstructured":"Chow CCN, Magnussen J, Ip J, Su Y. 2020 Acute transverse myelitis in COVID-19 infection. BMJ Case Rep.;13(8)","DOI":"10.1136\/bcr-2020-236720"},{"issue":"3","key":"2137_CR197","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5811\/cpcem.2020.5.47937","volume":"4","author":"D Sarma","year":"2020","unstructured":"Sarma D, Bilello LA (2020) A case report of acute transverse myelitis following novel coronavirus infection. Clin Pract Cases Emerg Med 4(3):321\u2013323","journal-title":"Clin Pract Cases Emerg Med"},{"key":"2137_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102749","volume":"69","author":"SA Ahmad","year":"2021","unstructured":"Ahmad SA, Salih KH, Ahmed SF, Kakamad FH, Salh AM, Hassan MN et al (2021) Post COVID-19 transverse myelitis; a case report with review of literature. Ann Med Surg (Lond) 69:102749","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"2137_CR199","first-page":"107","volume":"15","author":"H Nejad Biglari","year":"2021","unstructured":"Nejad Biglari H, Sinaei R, Pezeshki S, Khajeh HF (2021) Acute transverse myelitis of childhood due to novel coronavirus disease 2019: The first pediatric case report and review of literature. Iran J Child Neurol 15(1):107\u2013112","journal-title":"Iran J Child Neurol"},{"issue":"4","key":"2137_CR200","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.36740\/WLek202104144","volume":"74","author":"HV Palahuta","year":"2021","unstructured":"Palahuta HV, Fartushna OY, Yevtushenko SK, Hnepa YY (2021) Acute transverse myelitis as a neurological complication of covid-19: a case report. Wiad Lek 74(4):1045\u20131049","journal-title":"Wiad Lek"},{"issue":"4","key":"2137_CR201","volume":"14","author":"EC Lingas","year":"2022","unstructured":"Lingas EC (2022) A case of acute transverse myelitis in a mildly symptomatic patient: an emerging and serious neurological manifestation of COVID-19. Cureus 14(4):e24222","journal-title":"Cureus"},{"issue":"391","key":"2137_CR202","first-page":"e1","volume":"56","author":"S Prete","year":"2022","unstructured":"Prete S, McShannic JD, Fertel BS, Simon EL (2022) Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection. Am J Emerg Med 56(391):e1\u2013e3","journal-title":"Am J Emerg Med"},{"issue":"2","key":"2137_CR203","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s13365-021-00957-1","volume":"27","author":"H Shahali","year":"2021","unstructured":"Shahali H, Ghasemi A, Farahani RH, Nezami Asl A, Hazrati E (2021) Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia. J Neurovirol 27(2):354\u2013358","journal-title":"J Neurovirol"},{"key":"2137_CR204","doi-asserted-by":"crossref","unstructured":"Hsiao YT, Tsai MJ, Chen YH, Hsu CF. Acute transverse myelitis after COVID-19 vaccination. Medicina. 2021 Sep 25;57(10):1010.","DOI":"10.3390\/medicina57101010"},{"issue":"1","key":"2137_CR205","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12883-021-02427-x","volume":"21","author":"WY Tan","year":"2021","unstructured":"Tan WY, Yusof Khan AHK, Mohd Yaakob MN, Abdul Rashid AM, Loh WC, Baharin J et al (2021) Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC Neurol 21(1):395","journal-title":"BMC Neurol"},{"issue":"5","key":"2137_CR206","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.7861\/clinmed.2021-0470","volume":"21","author":"AA Notghi","year":"2021","unstructured":"Notghi AA, Atley J, Silva M (2021) Lessons of the month 1: longitudinal extensive transverse myelitis following astrazeneca covid-19 vaccination. Clin Med (Lond) 21(5):e535\u2013e538","journal-title":"Clin Med (Lond)"},{"issue":"7","key":"2137_CR207","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e52","volume":"37","author":"H Eom","year":"2022","unstructured":"Eom H, Kim SW, Kim M, Kim YE, Kim JH, Shin HY et al (2022) Case reports of acute transverse myelitis associated with mrna vaccine for COVID-19. J Korean Med Sci 37(7):e52","journal-title":"J Korean Med Sci"},{"issue":"5","key":"2137_CR208","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2169\/internalmedicine.8747-21","volume":"61","author":"N Miyaue","year":"2022","unstructured":"Miyaue N, Yoshida A, Yamanishi Y, Tada S, Ando R, Hosokawa Y et al (2022) Refractory longitudinally extensive transverse myelitis after severe acute respiratory syndrome coronavirus 2 vaccination in a Japanese man. Intern Med 61(5):739\u2013742","journal-title":"Intern Med"},{"issue":"1","key":"2137_CR209","doi-asserted-by":"publisher","first-page":"2040239","DOI":"10.1080\/21645515.2022.2040239","volume":"18","author":"SF Maroufi","year":"2022","unstructured":"Maroufi SF, Naderi Behdani F, Rezania F, Tanhapour Khotbehsara S, Mirzaasgari Z (2022) Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature. Hum Vaccin Immunother 18(1):2040239","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"2137_CR210","volume":"13","author":"N Tahir","year":"2021","unstructured":"Tahir N, Koorapati G, Prasad S, Jeelani HM, Sherchan R, Shrestha J et al (2021) SARS-CoV-2 vaccination-induced transverse myelitis. Cureus 13(7):e16624","journal-title":"Cureus"},{"issue":"51","key":"2137_CR211","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028423","volume":"100","author":"S Hirose","year":"2021","unstructured":"Hirose S, Hara M, Koda K, Natori N, Yokota Y, Ninomiya S et al (2021) Acute autoimmune transverse myelitis following COVID-19 vaccination: a case report. Medicine (Baltimore) 100(51):e28423","journal-title":"Medicine (Baltimore)"},{"key":"2137_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102912","volume":"71","author":"A Rajae","year":"2021","unstructured":"Rajae A, Manal M, Ghizlane EA, Amine B, Zaid I, Houssam B et al (2021) Ischemic stroke revealing covid-19 infection: case report. Ann Med Surg (Lond) 71:102912","journal-title":"Ann Med Surg (Lond)"},{"issue":"2","key":"2137_CR213","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000515457","volume":"13","author":"C Avvantaggiato","year":"2021","unstructured":"Avvantaggiato C, Amoruso L, Lo Muzio MP, Mimmo MA, Delli Bergoli M, Cinone N et al (2021) Ischemic stroke in a 29-year-old patient with covid-19: a case report. Case Rep Neurol 13(2):334\u2013340","journal-title":"Case Rep Neurol"},{"issue":"6","key":"2137_CR214","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s13365-020-00898-1","volume":"26","author":"G Bigliardi","year":"2020","unstructured":"Bigliardi G, Ciolli L, Giovannini G, Vandelli L, Dell\u2019Acqua ML, Borzi GM et al (2020) Middle cerebral artery ischemic stroke and COVID-19: a case report. J Neurovirol 26(6):967\u2013969","journal-title":"J Neurovirol"},{"issue":"1","key":"2137_CR215","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13000-020-00994-0","volume":"15","author":"P Zhai","year":"2020","unstructured":"Zhai P, Ding Y, Li Y (2020) The impact of COVID-19 on ischemic stroke. Diagn Pathol 15(1):78","journal-title":"Diagn Pathol"},{"issue":"9","key":"2137_CR216","volume":"12","author":"U Farooque","year":"2020","unstructured":"Farooque U, Shabih S, Karimi S, Lohano AK, Kataria S (2020) Coronavirus disease 2019-related acute ischemic stroke: a case report. Cureus 12(9):e10310","journal-title":"Cureus"},{"issue":"3","key":"2137_CR217","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/20009666.2021.1883814","volume":"11","author":"LF Owolabi","year":"2021","unstructured":"Owolabi LF, Raafat A, Enwere OO, Mustapha AF, Adamu B, AlGhamdi M (2021) Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature. J Community Hosp Intern Med Perspect 11(3):322\u2013326","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2137_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100274","author":"P Fraiman","year":"2020","unstructured":"Fraiman P, Freire M, Moreira-Neto M, Godeiro-Junior C (2020) Hemorrhagic stroke and COVID-19 infection: coincidence or causality. eNeurologicalSci. https:\/\/doi.org\/10.1016\/j.ensci.2020.100274","journal-title":"eNeurologicalSci"},{"issue":"10","key":"2137_CR219","volume":"12","author":"G Flores","year":"2020","unstructured":"Flores G, Kumar JI, Pressman E, Sack J, Alikhani P (2020) Spontaneous brainstem hemorrhagic stroke in the setting of novel coronavirus disease 2019 - a case report. Cureus 12(10):e10809","journal-title":"Cureus"},{"issue":"1","key":"2137_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105434","volume":"30","author":"K Dakay","year":"2021","unstructured":"Dakay K, Cooper J, Bloomfield J, Overby P, Mayer SA, Nuoman R et al (2021) Cerebral venous sinus thrombosis in COVID-19 Infection: a case series and review of the literature. J Stroke Cerebrovasc Dis 30(1):105434","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2137_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.741594","volume":"8","author":"M Anipindi","year":"2021","unstructured":"Anipindi M, Scott A, Joyce L, Wali S, Morginstin M (2021) Case report: cerebral venous sinus thrombosis and COVID-19 infection. Front Med (Lausanne) 8:741594","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"2137_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105379","volume":"29","author":"TM Tu","year":"2020","unstructured":"Tu TM, Goh C, Tan YK, Leow AS, Pang YZ, Chien J et al (2020) Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis 29(12):105379","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"2137_CR223","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.radcr.2022.02.082","volume":"17","author":"G Elaidouni","year":"2022","unstructured":"Elaidouni G, Chetouani Z, Manal Merbouh CB, Bkiyar H, Housni B (2022) Acute ischemic stroke after first dose of inactivated COVID-19 vaccine: a case report. Radiol Case Rep 17(6):1942\u20131945","journal-title":"Radiol Case Rep"},{"issue":"11","key":"2137_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106072","volume":"30","author":"J Kenda","year":"2021","unstructured":"Kenda J, Lovric D, Skerget M, Milivojevic N (2021) Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. J Stroke Cerebrovasc Dis 30(11):106072","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"2137_CR225","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/jnnp-2021-326984","volume":"92","author":"T Al-Mayhani","year":"2021","unstructured":"Al-Mayhani T, Saber S, Stubbs MJ, Losseff NA, Perry RJ, Simister RJ et al (2021) Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. J Neurol Neurosurg Psychiatry 92(11):1247\u20131248","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2137_CR226","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/ane.13505","volume":"144","author":"ML de Melo Silva","year":"2021","unstructured":"de Melo Silva ML, Jr., Lopes DP. (2021) Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report. Acta Neurol Scand 144(6):717\u2013718","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2137_CR227","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00701-021-05038-0","volume":"164","author":"R Takeyama","year":"2022","unstructured":"Takeyama R, Fukuda K, Kouzaki Y, Koga T, Hayashi S, Ohtani H et al (2022) Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta Neurochir 164(2):543\u2013547","journal-title":"Acta Neurochir"},{"issue":"8","key":"2137_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","volume":"30","author":"L Dias","year":"2021","unstructured":"Dias L, Soares-Dos-Reis R, Meira J, Ferrao D, Soares PR, Pastor A et al (2021) Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis 30(8):105906","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"2137_CR229","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00701-021-04860-w","volume":"163","author":"Z Zakaria","year":"2021","unstructured":"Zakaria Z, Sapiai NA, Ghani ARI (2021) Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta Neurochir (Wien) 163(8):2359\u20132362","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"2137_CR230","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm11040285","volume":"11","author":"V D'Agostino","year":"2021","unstructured":"D\u2019Agostino V, Caranci F, Negro A, Piscitelli V, Tuccillo B, Fasano F et al (2021) A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Pers Med 11(4):285","journal-title":"J Pers Med"},{"key":"2137_CR231","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246200","author":"SN Atta","year":"2021","unstructured":"Atta SN, Othman N, Babar M (2021) Cerebral venous sinus thrombosis secondary to ChAdOx-1 nCov-19 vaccine. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2021-246200","journal-title":"BMJ Case Rep"},{"issue":"12","key":"2137_CR232","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/ene.14478","volume":"27","author":"C Delorme","year":"2020","unstructured":"Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P et al (2020) COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography\/computed tomography findings. Eur J Neurol 27(12):2651\u20132657","journal-title":"Eur J Neurol"},{"key":"2137_CR233","doi-asserted-by":"publisher","first-page":"139","DOI":"10.11604\/pamj.2021.38.139.27845","volume":"38","author":"M Lazraq","year":"2021","unstructured":"Lazraq M, Benhamza S, Saadaoui S, Hayar S, Louardi M, Moujahid H et al (2021) Encephalopathy and COVID-19: a case report. Pan Afr Med J 38:139","journal-title":"Pan Afr Med J"},{"issue":"1","key":"2137_CR234","first-page":"26","volume":"5","author":"TB Goodloe 3rd","year":"2021","unstructured":"Goodloe TB 3rd, Walter LA (2021) COVID-19 presenting as encephalopathy in the emergency department: a case report. Clin Pract Cases Emerg Med 5(1):26\u201329","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"1","key":"2137_CR235","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13256-021-02851-0","volume":"15","author":"Z Teimouri-Jervekani","year":"2021","unstructured":"Teimouri-Jervekani Z, Salmasi M (2021) Presentation of COVID-19 infection with bizarre behavior and encephalopathy: a case report. J Med Case Rep 15(1):220","journal-title":"J Med Case Rep"},{"key":"2137_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102803","volume":"69","author":"AF Al-Mashdali","year":"2021","unstructured":"Al-Mashdali AF, Ata YM, Sadik N (2021) Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: a case report. Ann Med Surg (Lond) 69:102803","journal-title":"Ann Med Surg (Lond)"},{"issue":"7","key":"2137_CR237","volume":"13","author":"BD Liu","year":"2021","unstructured":"Liu BD, Ugolini C, Jha P (2021) Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus. Cureus 13(7):e16172","journal-title":"Cureus"},{"key":"2137_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.872734","volume":"13","author":"MR Bensaidane","year":"2022","unstructured":"Bensaidane MR, Picher-Martel V, Emond F, De Serres G, Dupre N, Beauchemin P (2022) Case report: acute necrotizing encephalopathy following COVID-19 vaccine. Front Neurol 13:872734","journal-title":"Front Neurol"},{"key":"2137_CR239","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2020.07.006","volume":"81","author":"G Monti","year":"2020","unstructured":"Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM et al (2020) Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 81:18\u201320","journal-title":"Seizure"},{"issue":"6","key":"2137_CR240","volume":"12","author":"S Bhatta","year":"2020","unstructured":"Bhatta S, Sayed A, Ranabhat B, Bhatta RK, Acharya Y (2020) New-onset seizure as the only presentation in a child with COVID-19. Cureus 12(6):e8820","journal-title":"Cureus"},{"key":"2137_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2021.100447","volume":"16","author":"S Park","year":"2021","unstructured":"Park S, Majoka H, Sheikh A, Ali I (2021) A presumed case of new-onset focal seizures as a delayed complication of COVID-19 infection. Epilepsy Behav Rep 16:100447","journal-title":"Epilepsy Behav Rep"},{"issue":"1","key":"2137_CR242","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10072-020-04846-z","volume":"42","author":"F Dono","year":"2021","unstructured":"Dono F, Carrarini C, Russo M, De Angelis MV, Anzellotti F, Onofrj M et al (2021) New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurol Sci 42(1):35\u201338","journal-title":"Neurol Sci"},{"issue":"12","key":"2137_CR243","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e97","volume":"37","author":"YJ Cho","year":"2022","unstructured":"Cho YJ, Kim HK (2022) New-onset seizures in patients with COVID-19: A case series from a single public hospital in Korea. J Korean Med Sci 37(12):e97","journal-title":"J Korean Med Sci"},{"key":"2137_CR244","doi-asserted-by":"crossref","unstructured":"Bauman K, Rosenthal J, Lin J. New-Onset Refractory Status Epilepticus After Pfizer-BioNTech COVID-19 Vaccination (P3-8.006). Neurology. 2022;98(18 Supplement):3631.","DOI":"10.1212\/WNL.98.18_supplement.3631"},{"issue":"1","key":"2137_CR245","volume":"13","author":"HD Desai","year":"2021","unstructured":"Desai HD, Sharma K, Patoliya JV, Ahadov E, Patel NN (2021) A rare case of Varicella-Zoster virus reactivation following recovery from COVID-19. Cureus 13(1):e12423","journal-title":"Cureus"},{"key":"2137_CR246","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X211065793","author":"W Saleh","year":"2021","unstructured":"Saleh W, Ata F, Elashry MM (2021) Is COVID-19 infection triggering oral herpes zoster? A case report. SAGE Open Med Case Rep. https:\/\/doi.org\/10.1177\/2050313X211065793","journal-title":"SAGE Open Med Case Rep"},{"key":"2137_CR247","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijid.2021.08.048","volume":"111","author":"CS van Dam","year":"2021","unstructured":"van Dam CS, Lede I, Schaar J, Al-Dulaimy M, R\u00f6sken R, Smits M (2021) Herpes zoster after COVID vaccination. Int J Infect Dis 111:169\u2013171","journal-title":"Int J Infect Dis"},{"key":"2137_CR248","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","volume":"12","author":"P Rodriguez-Jimenez","year":"2021","unstructured":"Rodriguez-Jimenez P, Chicharro P, Cabrera LM, Segui M, Morales-Caballero A, Llamas-Velasco M et al (2021) Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep 12:58\u201359","journal-title":"JAAD Case Rep"},{"issue":"9","key":"2137_CR249","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00011-021-01491-w","volume":"70","author":"LS Santovito","year":"2021","unstructured":"Santovito LS, Pinna G (2021) A case of reactivation of varicella-zoster virus after BNT162b2 vaccine second dose? Inflamm Res 70(9):935\u2013937","journal-title":"Inflamm Res"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02137-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-02137-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02137-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:32:45Z","timestamp":1728397965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-02137-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":249,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-02137-2","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Terence T. Sio reports that he provides strategic and scientific recommendations as a member of the Advisory Board and speaker for Novocure, Inc. and also as a member of the Advisory Board to Galera Therapeutics, which are not in any way associated with the content or disease site as presented in this manuscript. All other authors have no relevant financial interests to be declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}